UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 40-F/A
[Check One]
Registration Statement Pursuant to Section 12 of the
Securities Exchange Act of 1934
- ------
Annual Report Pursuant to Section 13(a) or 15(d) of the
X Securities Exchange Act of 1934
- ------
For the fiscal year ended: September 30, 2003 Commission File Number:
-------------------- ---------
Axcan Pharma Inc.
- --------------------------------------------------------------------------------
(Exact name of Registrant as specified in its charter)
N/A
- --------------------------------------------------------------------------------
(Translation of Registrant's name into English (if applicable))
Canada
- --------------------------------------------------------------------------------
(Province or other jurisdiction of incorporation or organization)
5122
- --------------------------------------------------------------------------------
(Primary Standard Industrial Classification Code Number (if applicable))
N/A
- --------------------------------------------------------------------------------
(I.R.S. Employer Identification Number (if applicable))
597 Laurier Blvd., Mont St-Hilaire, Quebec, Canada J3H 6C4 (450) 467-5138
- --------------------------------------------------------------------------------
(Address and telephone number of Registrant's principal executive offices)
CT Corporation System, 111 8th Avenue, 15th Floor, New York,
New York 10011 (212) 894-8700
- --------------------------------------------------------------------------------
(Name, address (including zip code) and telephone number
(including area code of agent for service in the United States)
Securities registered or to be registered pursuant to Section 12(b) of the Act.
Title of each class Name of each exchange on which registered
None
- ----------------------------- -------------------------------------------
- ----------------------------- -------------------------------------------
Securities registered or to be registered pursuant to Section 12(g) of the Act.
Common Shares
- --------------------------------------------------------------------------------
(Title of Class)
Securities for which there is a reporting obligation pursuant to Section 15(d)
of the Act.
Common Shares
- --------------------------------------------------------------------------------
(Title of Class)
For annual reports, indicate by check mark the information filed with this Form:
X Annual information form Audited annual financial statements
----- ----
Indicate the number of outstanding shares of each of the issuer's
classes of capital or common stock as of the close of the period covered by the
annual report.
Common Shares 45,004,320
- --------------------------------------------------------------------------------
Indicate by check mark whether the Registrant by filing the information
contained in this Form is also thereby furnishing the information to the
Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934
(the "Exchange Act"). If "Yes" is marked, indicate the filing number assigned to
the Registrant in connection with such Rule.
Yes __ No X
-
Indicate by check mark whether the Registrant (1) has filed all reports
required to be filed by Section 13 or 15(d) of the Exchange Act during the
preceding 12 months (or for such shorter period that the Registrant was required
to file such reports) and (2) has been subject to such filing requirements for
the past 90 days.
Yes X No __
---
.................................................................................
Registrant undertakes to make available, in person or by telephone,
representatives to respond to inquiries made by the Commission staff, and to
furnish promptly, when requested to do so by the Commission staff, information
relating to: the securities registered pursuant to Form 40-F; the securities in
relation to which the obligation to file an annual report on Form 40-F arises;
or transactions in said securities.
EXPLANATORY NOTES
This Form 40-F/A amends the Form 40-F filed by the Registrant on
January, 2004 to add the Registrant's Annual Information Form as an Exhibit.
SIGNATURES
Pursuant to the requirements of the Exchange Act, the Registrant
certifies that it meets all of the requirements for filing on Form 40-F and has
duly caused this annual report to be signed on its behalf by the undersigned,
thereto duly authorized.
AXCAN PHARMA INC.
(Registrant)
Date: February 20, 2004 By: /s/ Jean Vezina
-------------------------
Jean Vezina
Vice President, Finance and
Chief Financial Officer
EXHIBITS
99.1* Additional disclosures required pursuant to Form 40-F instructions.
99.2* Management's Discussion and Analysis - Pages 16 - 27 of Axcan's 2003
Annual Report
99.3* Consolidated Financial Statements, U.S. GAAP - Pages 29 - 58 of Axcan's
2003 Annual Report
99.4* Consolidated Financial Statements, Canadian GAAP - Pages 59 - 85 of
Axcan's 2003 Annual Report
99.5 Rule 13a-14(a) Certificate
99.6 Rule 13a-14(a) Certificate
99.7 Certification Pursuant to 18 U.S.C. Section 1350
99.8 Certification Pursuant to 18 U.S.C. Section 1350
99.9* Consent of Independent Public Accountants
99.10 Annual Information Form for the Year Ended September 30, 2003.
*Previously Filed